![Page 1: Department of Dermatology, University of Michigan, Ann](https://reader035.vdocuments.mx/reader035/viewer/2022081613/62c7e52c3d301738a935c26b/html5/thumbnails/1.jpg)
Dermatologist Perceptions of Teledermatology Implementation
& Future Use Post COVID-19 Linda Camaj Deda
University of Michigan Medical School, Ann ArborDepartment of Dermatology, University of Michigan, Ann Arbor
![Page 2: Department of Dermatology, University of Michigan, Ann](https://reader035.vdocuments.mx/reader035/viewer/2022081613/62c7e52c3d301738a935c26b/html5/thumbnails/2.jpg)
AAD Taskforce Collaborators
Rebecca Goldberg, BSTrilokraj Tejasvi, MBBS, MD
Jules B. Lipoff, MDJonathan Kennedy, BS
Siobhan Arey, MPH, MS, PA-CZachary Hopkins, MD
Ramsay Farah, MDAaron M. Secrest, MD, PhD
George Han, MDJason G. Mathis, MD
Rosie Balk, MAMartha Wojtowycz, PhD
![Page 3: Department of Dermatology, University of Michigan, Ann](https://reader035.vdocuments.mx/reader035/viewer/2022081613/62c7e52c3d301738a935c26b/html5/thumbnails/3.jpg)
Changes in Teledermatology in Setting of COVID-19 Pandemic
![Page 4: Department of Dermatology, University of Michigan, Ann](https://reader035.vdocuments.mx/reader035/viewer/2022081613/62c7e52c3d301738a935c26b/html5/thumbnails/4.jpg)
Regulatory Changes from the US Centers for Medicare & Medicaid Services
Parity in reimbursement between in-person and video visits
Removing eligibility and geographic restrictions
![Page 5: Department of Dermatology, University of Michigan, Ann](https://reader035.vdocuments.mx/reader035/viewer/2022081613/62c7e52c3d301738a935c26b/html5/thumbnails/5.jpg)
Methods
TopicsModes Used Situational Appropriateness Reimbursement Perceived NeedBarriers Anticipated Future Use
In May-June 2020, AAD Task Force Subgroup surveyed AAD members regarding effects of COVID-19 on teledermatology
![Page 6: Department of Dermatology, University of Michigan, Ann](https://reader035.vdocuments.mx/reader035/viewer/2022081613/62c7e52c3d301738a935c26b/html5/thumbnails/6.jpg)
12,070 practicing US dermatologist members of AAD
5,000 randomly selected
4,356 received the survey
591 completed surveys (13.6% response rate)
➥ 644 non-functioning email addresses
![Page 7: Department of Dermatology, University of Michigan, Ann](https://reader035.vdocuments.mx/reader035/viewer/2022081613/62c7e52c3d301738a935c26b/html5/thumbnails/7.jpg)
Results
14% 97%Prior COVID-19 During COVID-19
Anticipated personal continued use
70%
Teledermatology Utilization
Anticipated Future of Teledermatology
58%Believed teledermatology
will continue post-pandemic
![Page 8: Department of Dermatology, University of Michigan, Ann](https://reader035.vdocuments.mx/reader035/viewer/2022081613/62c7e52c3d301738a935c26b/html5/thumbnails/8.jpg)
ResultsAppropriate Utilization
LO, live office visitLV, live video visitSDP, stored digital photography
96%
3%
![Page 9: Department of Dermatology, University of Michigan, Ann](https://reader035.vdocuments.mx/reader035/viewer/2022081613/62c7e52c3d301738a935c26b/html5/thumbnails/9.jpg)
ResultsBarriers
Technology Issues (39%)
Low Reimbursement (70%)
Malpractice/Liability Concerns (27%)
Government Regulations (23%)
![Page 10: Department of Dermatology, University of Michigan, Ann](https://reader035.vdocuments.mx/reader035/viewer/2022081613/62c7e52c3d301738a935c26b/html5/thumbnails/10.jpg)
Conclusions➥ Teledermatology is likely here to stay.
➥ There are concerns highlighting the need for supportive reimbursement, regulations, and technological innovation (improved connectivity and functionality of video visit platforms).
➥ Refinement of workflow by patient and visit-type selection will likely improve how teledermatology is perceived by dermatologists.
We hope that this data can inform policy changes to address barriers to use.
![Page 11: Department of Dermatology, University of Michigan, Ann](https://reader035.vdocuments.mx/reader035/viewer/2022081613/62c7e52c3d301738a935c26b/html5/thumbnails/11.jpg)
Cited SourcesCoates SJ, Kvedar J, Granstein RD. Teledermatology: from historical perspective to emerging techniques of the modern era: part I: history, rationale, and current practice. J Am Acad Dermatol. 2015;72(4):563-574. doi:10.1016/j.jaad.2014.07.061PubMedGoogle ScholarCrossref
Harvey JB, Valenta S, Simpson K, Lyles M, McElligott J. Utilization of outpatient telehealth services in parity and nonparity states 2010-2015. Telemed J E Health. 2019;25(2):132-136. doi:10.1089/tmj.2017.0265PubMedGoogle ScholarCrossref
Lee I, Kovarik C, Tejasvi T, Pizarro M, Lipoff JB. Telehealth: helping your patients and practice survive and thrive during the COVID-19 crisis with rapid quality implementation. J Am Acad Dermatol. 2020;82(5):1213-1214. doi:10.1016/j.jaad.2020.03.052PubMedGoogle ScholarCrossref
US Centers for Disease Control and Prevention. Using telehealth to expand access to essential health services during the COVID-19 pandemic. Updated June 10, 2020. Accessed July 18, 2020. https://www.cdc.gov/coronavirus/2019-ncov/hcp/telehealth.html
Perkins S, Cohen JM, Nelson CA, Bunick CG. Teledermatology in the era of COVID-19: experience of an academic department of dermatology. J Am Acad Dermatol. 2020;83(1):e43-e44. doi:10.1016/j.jaad.2020.04.048PubMedGoogle ScholarCrossref
Cited ImagesCenters for Medicare and Medicaid Services logo, 1 April 2014, CMS Branding Guidelines, Centers for Medicare and Medicaid Services. As a work of the U.S. federal government, the image is in the public domain.
The greater coat of arms of the United States of America. Ssolbergj, CC BY-SA 3.0 <https://creativecommons.org/licenses/by-sa/3.0>, via Wikimedia Commons
Stock Photos, Canva (2021)